These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8833896)

  • 1. Molecular hemostatic variant enhances warfarin toxicity.
    Thompson AR
    J Clin Invest; 1996 Oct; 98(7):1508. PubMed ID: 8833896
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic management of a patient with a unique factor IX sensitivity to warfarin.
    Scialla S; Rubin R; Liptock KM
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):73-4; discussion 74-5. PubMed ID: 16562374
    [No Abstract]   [Full Text] [Related]  

  • 3. Ala-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin.
    Baker P; Clarke K; Giangrande P; Keeling D
    Br J Haematol; 2000 Mar; 108(3):663. PubMed ID: 10847705
    [No Abstract]   [Full Text] [Related]  

  • 4. Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.
    Kristensen SR
    Blood; 2002 Oct; 100(7):2676-7. PubMed ID: 12360981
    [No Abstract]   [Full Text] [Related]  

  • 5. The Conundrum of "Warfarin Hypersensitivity": Prolonged Partial Thromboplastin Time From Factor IX Propeptide Mutation.
    Sekhri A; Lisinschi A; Furqan M; Palaniswamy C; Mukhi N; Gupta R; Nelson JC
    Am J Ther; 2016; 23(3):e911-5. PubMed ID: 24832385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor IX metal ion-dependent antigen assays for measurement of warfarin effect.
    Smith KJ; Singaraju C; Smith LF
    Am J Clin Pathol; 1987 Mar; 87(3):370-6. PubMed ID: 3826002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miconazole-warfarin interaction: increased INR.
    Murty M
    CMAJ; 2001 Jul; 165(1):81-2, 85-6. PubMed ID: 11468962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous toxicity of anticoagulant warfarin in rats.
    Kataranovski M; Mirkov I; Vrankovic J; Kataranovski D; Subota V
    Cutan Ocul Toxicol; 2008; 27(1):29-40. PubMed ID: 18330832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prothrombin complex concentrate important in warfarin induced hemorrhage].
    Holmström M
    Lakartidningen; 2009 Sep 9-15; 106(37):2270. PubMed ID: 19817159
    [No Abstract]   [Full Text] [Related]  

  • 11. Is age a risk factor for warfarin-related major bleeds in elderly patients with atrial fibrillation?
    Cheng HY
    J Am Geriatr Soc; 2006 Jul; 54(7):1155. PubMed ID: 16866702
    [No Abstract]   [Full Text] [Related]  

  • 12. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage.
    Safaoui MN; Aazami R; Hotz H; Wilson MT; Margulies DR
    Am J Surg; 2009 Jun; 197(6):785-90. PubMed ID: 18722586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warning label added to common blood thinner: how to stay safe.
    Johns Hopkins Med Lett Health After 50; 2007 Mar; 19(1):1, 8. PubMed ID: 17342838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxicity of warfarin and its effect on blood coagulation in rat and mice].
    Niedner R; Kayser M; Reuter N; Meyer F; Perkow W
    Arzneimittelforschung; 1973 Jan; 23(1):102. PubMed ID: 4740693
    [No Abstract]   [Full Text] [Related]  

  • 15. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-response experiments with anticoagulants on rats.
    Tammes PM; Loosjes FE; Wijnen R
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):423-33. PubMed ID: 5582711
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy.
    Samardzija M; Topić E; Stefanović M; Zibar L; Samardzija G; Balen S; Vcev A; Domanović D; Mirat J; Barbić J
    Coll Antropol; 2008 Jun; 32(2):557-64. PubMed ID: 18756910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the risk of bleeding in warfarin therapy.
    Ebell MH
    J Fam Pract; 1999 Jun; 48(6):413. PubMed ID: 10386476
    [No Abstract]   [Full Text] [Related]  

  • 20. Are major bleeding events from falls more likely in patients on warfarin?
    Garvin R; Howard E
    J Fam Pract; 2006 Feb; 55(2):159-60; discussion 159. PubMed ID: 16451785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.